HPS Pharmacies wish to advise that Hospira have given notice of the unavailability of supplies of;
DBL® Hyoscine Injection BP
400mcg/1mL, 5 x 1mL
This shortage is expected to extend through January and February 2014. The overseas manufacturer is experiencing difficulties and has advised that supply may be inconsistent for several months.
Although no other brands of hyoscine hydrobromide injection are registered in Australia, as other medicines may be substituted, Hospira will not seek an alternative supplier.
In order to restrict supply to those patients most in need, Hospira will only distribute remaining stocks of DBL® Hyoscine Injection BP on the individual application of medical practitioners.
Please retain this notice in a prominent position, including other related business units as a reminder for all staff members until supply returns to normal.
Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies or Hospira Customer Service on 1300 3046 774 (option 1) or Medical Information on 1300 046 774 (option 2).
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.